National expertise in medicinal chemistry, drug discovery and therapeutic translation
The ATMCF is a member of a National Research Infrastructure for Australia integrated capability network that supports Small Molecule Drug Discovery. Delivered by Therapeutic Innovation Australia, these connected facilities provide expertise and infrastructure to support cutting-edge drug discovery research and boost innovation across Australia. For an overview of the TIA capabilities, please visit the TIA website.
MedChem Australia's purpose is to work with the Australian biomedical research and biotech community to develop new medicines through creativity and collaboration. MedChem Australia provides expert medicinal chemistry & DMPK capability to enhance and accelerate the development of new small molecule therapeutics. Three of the nation’s top medicinal chemistry groups from Monash University, WEHI and the University of Sydney, along with the Centre for Drug Candidate Optimisation make up MedChem Australia. To find out more, visit the MedChem Australia website.
Our lab has been certified by My Green Lab as achieving Green status, the highest level within their internationally recognised laboratory sustainability certification framework. This achievement reflects the dedication of our staff and our ongoing commitment to continuous improvement in sustainable laboratory practices.
